Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1991480

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1991480

Global Veterinary Molecular Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 186 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The Veterinary Molecular Diagnostics Market size is expected to reach USD 5.34 Billion in 2034 from USD 2.06 Billion (2025) growing at a CAGR of 11.14% during 2026-2034.

The global veterinary molecular diagnostics market has grown as animal healthcare and disease detection technologies continue to advance. Veterinary molecular diagnostics involve the use of advanced laboratory techniques such as polymerase chain reaction and DNA analysis to detect infectious diseases in animals. These methods provide accurate and rapid identification of pathogens affecting livestock and companion animals.

Several factors are driving the growth of this market. The increasing demand for effective disease monitoring in livestock production has encouraged the use of advanced diagnostic tools. Farmers and veterinarians rely on molecular diagnostics to detect diseases early and prevent outbreaks. In addition, rising pet ownership has increased the need for advanced diagnostic services in veterinary clinics.

The future outlook for the veterinary molecular diagnostics market remains promising as animal health management becomes more sophisticated. Advances in genetic testing and portable diagnostic technologies may improve disease detection and monitoring capabilities. Increasing investments in veterinary healthcare and livestock management are expected to support market expansion. As the importance of animal health continues to grow, demand for molecular diagnostic technologies will likely increase.

MARKET SEGMENTATION

By Product

  • Instruments
  • Test Kits & Reagents
  • Software & Services

By Animal Type Outlook

  • Companion Animal
  • Production Animals

By Technology

  • PCR
  • DNA Sequencing
  • Microarrays
  • INAAT Kits

By Application

  • Infectious Diseases
  • Metabolic Disease
  • Genetics
  • Other Application

By End-use

  • Veterinary Hospitals & Clinics
  • Diagnostic Laboratories
  • Other End-use

COMPANIES PROFILED

  • Zoetis, IDEXX, Antech Diagnostics Inc Mars Inc, Thermo Fisher Scientific Inc, Neogen Corporation, Gold Standard Diagnostics Eurofins Technologies, BioRad Laboratories Inc, Ring Biotechnology Co Ltd, QIAGEN NV, BIONOTE
  • We can customise the report as per your requirements.
Product Code: VMR11214150

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Test Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY ANIMAL TYPE OUTLOOK 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Animal Type Outlook
  • 5.2. Companion Animal Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Production Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Technology
  • 6.2. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. DNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. INAAT Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Metabolic Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Genetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Other Application Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Veterinary Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Other End-use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Animal Type Outlook
    • 9.2.3 By Technology
    • 9.2.4 By Application
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Animal Type Outlook
    • 9.3.3 By Technology
    • 9.3.4 By Application
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Animal Type Outlook
    • 9.4.3 By Technology
    • 9.4.4 By Application
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Animal Type Outlook
    • 9.5.3 By Technology
    • 9.5.4 By Application
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Animal Type Outlook
    • 9.6.3 By Technology
    • 9.6.4 By Application
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY MOLECULAR DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Zoetis
    • 11.2.2 IDEXX
    • 11.2.3 Antech Diagnostics Inc. (Mars Inc.)
    • 11.2.4 Thermo Fisher Scientific Inc
    • 11.2.5 Neogen Corporation
    • 11.2.6 Gold Standard Diagnostics (Eurofins Technologies)
    • 11.2.7 Bio-Rad Laboratories Inc
    • 11.2.8 Ring Biotechnology Co Ltd
    • 11.2.9 QIAGEN N.V
    • 11.2.10 BIONOTE
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!